List of Ulesfia drug patents
Ulesfia is owned by Shionogi Inc.
Ulesfia contains Benzyl Alcohol.
Ulesfia has a total of 2 drug patents out of which 1 drug patent has expired.
Expired drug patents of Ulesfia are:
- US6793931
Ulesfia was authorised for market use on 09 April, 2009.
Ulesfia is available in lotion;topical dosage forms.
Ulesfia can be used as topical treatment of lice infestations.
The generics of Ulesfia are possible to be released after 19 May, 2024.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6793931 | SHIONOGI INC | Ectoparasite asphyxiator compositions and methods for their applications |
Jul, 2022
(6 months ago) | |
| US7294342 | SHIONOGI INC | Ectoparasite asphyxiator compositions and methods for their application |
May, 2024
(1 year, 3 months from now) | |
Drugs and Companies using BENZYL ALCOHOL ingredient
Market Authorisation Date: 09 April, 2009
Treatment: Topical treatment of lice infestations
Dosage: LOTION;TOPICAL
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic